SEC Form 4 · accession 0001209191-16-106546
INVACARE CORP · IVC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony LaPlaca
Officer — Sr. VP and General Counsel
Period of report
Mar 3, 2016
Accepted (ET)
Mar 7, 2016 · 4:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000742112
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Mar 3, 2016 | A | 11,390 | $0.00 | A | 39,074 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F3,F2 | — | holding | — | — | — | — | — | Common Shares | 86,700 | 86,700 | D |
Explanation of responses
- F1Restricted shares granted pursuant to the Invacare Corporation 2013 Equity Compensation Plan in an exempt transaction under Rule 16b-3. These shares vest in 1/3 annual increments over three years commencing on May 15, 2017.
- F2No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
- F3The reporting person holds previously reported options to buy 86,700 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted between October 27, 2008 and March 18, 2013, at exercise prices between $13.37 to $25.24 per share, will expire between October 27, 2018 and March 18, 2023, and became or will become exercisable between September 30, 2009 and March 31, 2017.